1 |
Polyhydroxybutyrate/poly(ε-caprolactone)/silica nanoparticles (PHB/PCL/SNPs) |
Electrospinning, Sol-gel, Dispersion electrospinning |
MG-63 |
In vitro |
Enhanced viability, ALP activity |
[33] |
2 |
Bone forming peptide/SNPs |
Covalent cross-linking |
stem cells (hMSCs) |
In vitro & In vivo |
Enhanced cell adhesion, Survivability, Proliferation, Expansion and osteogenesis |
[112] |
3 |
Polyamidoamine/SNPs |
Covalent cross-linking |
mBM-MSC |
In vitro & In vivo |
Enhanced viability, biocompatibility, proliferation, Mechanical properties, |
[114] |
4 |
Poly(l-lactide acid)/silica nanoparticles (PLLA/SNPs) |
Double sonication |
Simulated body fluid (SBF) |
In vitro |
Enhanced mechanical properties, |
[113] |
5 |
Polylactic acid/silica nanoparticles (PLA/SNPs) |
Melt mixing |
MC3T3-E1 |
In vitro |
Enhanced viability, proliferation and thermomechanical properties, Biodegradability |
[111] |
6 |
collagen-chitosan/SNPs |
in situ gelation (Stober method) |
Simulated body fluid (SBF) |
In vitro |
Enhanced viability, Low toxicity |
[118] |
7 |
Polycaprolactone Fibrous/SNPs |
Electrostatic layer-by-layer self-assembly |
hFOB 1.19 |
In vitro |
Enhanced cell attachment, proliferation, and ALP |
[58] |